Financhill
Sell
45

CMPX Quote, Financials, Valuation and Earnings

Last price:
$5.26
Seasonality move :
2.61%
Day range:
$5.09 - $5.39
52-week range:
$1.33 - $5.86
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
4.36x
Volume:
1.6M
Avg. volume:
2M
1-year change:
211.52%
Market cap:
$914.2M
Revenue:
$850K
EPS (TTM):
-$0.46

Earnings Data

Next earnings date for CMPX
Feb 26
2026
Most recent earnings per share
-$0.08
Beat by $0.05
(Nov 5/2025)
Consensus Estimate
-$0.13
(Nov 5/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CMPX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/26/2026 Q4 -- -- -- -$0.09 --
11/05/2025 Q3 -- -- -$0.08 -$0.13 $0.05
08/11/2025 Q2 -- -- -$0.14 -$0.12 -$0.03
05/15/2025 Q1 -- -- -$0.12 -$0.11 -$0.01
02/27/2025 Q4 -- -- -$0.11 -$0.09 -$0.01
11/12/2024 Q3 -- -- -$0.08 -$0.11 $0.03
08/12/2024 Q2 -- $850K -$0.10 -$0.10 --
05/13/2024 Q1 -- -- -$0.08 -$0.11 $0.03
03/21/2024 Q4 -- -- -$0.11 -$0.09 -$0.02
11/09/2023 Q3 -- -- -$0.08 -- --
08/03/2023 Q2 -- -- -$0.09 -- --
05/04/2023 Q1 -- -- -$0.06 -- --
03/15/2023 Q4 -- -- -$0.10 -- --
11/09/2022 Q3 -- -- -$0.12 -- --
08/01/2022 Q2 -- -- -$0.08 -- --
05/09/2022 Q1 -- -- -$0.07 -- --
03/21/2022 Q4 -- -- -$0.13 -- --
11/12/2021 Q3 -- -- -$0.10 -- --
08/16/2021 Q2 -- -- -$1.08 -- --
03/31/2021 Q1 -- -- -$0.14 -- --
12/31/2020 Q4 -- -- -$0.16 -- --
09/30/2020 Q3 -- -- -$0.18 -- --
06/30/2020 Q2 -- -- -$0.11 -- --
03/31/2020 Q1 -- -- -$0.12 -- --
12/31/2019 Q4 -- -- -$0.13 -- --
09/30/2019 Q3 -- -- -$0.16 -- --
06/30/2019 Q2 -- -- -$0.17 -- --
03/31/2019 Q1 -- -- -$0.21 -- --

Compass Therapeutics, Inc. Earnings Questions

  • How Much did Compass Therapeutics, Inc. Generate in Revenue Last Quarter?

    Compass Therapeutics, Inc. reported -- worth of top line sales in its most recent quarter.

  • Did Compass Therapeutics, Inc. Beat Earnings Last Quarter?

    Compass Therapeutics, Inc. announced earnings per share of -$0.08 which represents a beat of analyst forecast a -$0.13 per share.

  • Is Compass Therapeutics, Inc. Profitable?

    Compass Therapeutics, Inc. reported -$371K that represents -$0.00 per share over the last quarter.

  • What is the Analyst Consensus for Compass Therapeutics, Inc. EPS Next Year?

    Compass Therapeutics, Inc.'s earnings are forecast to decrease from -$0.36 per share to -$0.34 per share next year representing a decrease of -18.6%.

  • When is Compass Therapeutics, Inc.'s Earnings Date?

    Compass Therapeutics, Inc.'s next earnings date is February 26, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is JetBlue The Best Airline Stock?
Is JetBlue The Best Airline Stock?

Following a general trend of improvement among airline stocks, shares…

Why Did Netflix Buy Warner Bros?
Why Did Netflix Buy Warner Bros?

Following a bidding war, Netflix (NASDAQ:NFLX) has announced its intention…

Why Did SoFi Stock Drop?
Why Did SoFi Stock Drop?

Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…

Stock Ideas

Buy
64
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
56
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
59
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 40x

Alerts

Buy
84
TSAT alert for Dec 10

Telesat Corp. [TSAT] is up 3.07% over the past day.

Sell
6
ODC alert for Dec 10

Oil-Dri Corp. of America [ODC] is up 3.07% over the past day.

Buy
84
PAAS alert for Dec 10

Pan American Silver Corp. [PAAS] is up 0.5% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock